Huirong Mai
- Hematology top 10%
- Acute Myeloid Leukemia Research 11
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 3
-
- Chronic Lymphocytic Leukemia Research 3
-
- Acute Lymphoblastic Leukemia research 14
-
- Neutropenia and Cancer Infections 6
-
- Epigenetics and DNA Methylation 5
- Retinoids in leukemia and cellular processes 3
-
- Childhood Cancer Survivors' Quality of Life 4
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Huirong Mai
43 papers receiving 345 citations
Peers
Comparison fields: 5 of 67
- Hematology 126
- Molecular Medicine 36
- Applied Microbiology and Biotechnology 12
- Immunology 71
- Genetics 33
Countries citing papers authored by Huirong Mai
This map shows the geographic impact of Huirong Mai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huirong Mai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huirong Mai more than expected).
Fields of papers citing papers by Huirong Mai
This network shows the impact of papers produced by Huirong Mai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huirong Mai. The network helps show where Huirong Mai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huirong Mai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 29 | |
| 14 | 2022 | 17 | |
| 15 | 2022 | 6 | |
| 16 | 2020 | 1 | |
| 17 | 2019 | 2 | |
| 18 | 2017 | 9 | |
| 19 | 2017 | 1 | |
| 20 | 2012 | 14 |
About Huirong Mai
Huirong Mai is a scholar working on Hematology, Genetics and Molecular Medicine, having authored 46 papers that have together received 347 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (11 papers), Neutropenia and Cancer Infections (6 papers), Epigenetics and DNA Methylation (5 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Retinoids in leukemia and cellular processes (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Hematology (126 citations), Molecular Medicine (36 citations) and Applied Microbiology and Biotechnology (12 citations). Huirong Mai has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Feiqiu Wen, Sixi Liu, Xiaowen Chen, Changgang Li, Sandip Patil, Bruno S. Lopes, Jingshi Wang, Hui Li, Haixia Guo and Yixin Chen. Their work appears in journals such as Blood, PLoS ONE and Genome biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.